SCHEMBL14355393

SCHEMBL14355393

C#COc1nc(Nc2cccc(OC[C@@H](O)CN3CCC3)c2)ncc1Br

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ACE2 Q9BYF1 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ABCB1 P08183 4/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ PRMT5 O14744 3/20 0.41
▸ WDR77 Q9BQA1 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CDK4 P11802 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14355406 1.00 SMN1; SMN2 (0.48) SMN1; SMN2ACE2NPSR1KDM4EL3MBTL1
SCHEMBL14355396 0.93 KDM4E (0.44) SMN1; SMN2ACE2KDM4EL3MBTL1PRMT5
SCHEMBL14355400 0.93 KDM4E (0.44) SMN1; SMN2ACE2KDM4EL3MBTL1PRMT5
SCHEMBL13648685 0.91 SMN1; SMN2 (0.47) SMN1; SMN2ACE2NPSR1KDM4EL3MBTL1
SCHEMBL13648686 0.91 SMN1; SMN2 (0.47) SMN1; SMN2ACE2NPSR1KDM4EL3MBTL1
SCHEMBL14355398 0.88 DRD4 (0.54) ABCB1TSHRGAAATM
SCHEMBL14355401 0.88 DRD4 (0.54) ABCB1TSHRGAAATM
SCHEMBL13655128 0.86 SMN1; SMN2 (0.54) SMN1; SMN2ACE2NPSR1KDM4EL3MBTL1
SCHEMBL13655353 0.86 SMN1; SMN2 (0.54) SMN1; SMN2ACE2NPSR1KDM4EL3MBTL1
SCHEMBL13648688 0.83 KDM4E (0.44) SMN1; SMN2ACE2KDM4EPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291624-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2007-11-06 — — US disclosed
US-7291624-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2007-11-06 — — US disclosed
Send feedback